Ifosfamide
Anaplastic Astrocytoma of Brain
Oliver JonasEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 24/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Anaplastic Astrocytoma of Brain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
g207 Pediatric Brain Tumor Consortium | Phase 2 | CCC |
c134 James Markert, MD | Phase 1 | CC |
Same molecule, other indications
Ifosfamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →